Skip to main content
. 2024 May 10;24:485. doi: 10.1186/s12879-024-09308-x

Table 4.

Analysis of treatment plans and prognoses of 21 patients with NB

Program Course of treatment in hospital (days) Number of cases Prognosis
Get better Unhealed Unknown
Dual therapy Doxycycline 0.1 g bid + rifampicin 0.45 g qd 3–12 4 2 1 1
Doxycycline 0.1 g bid + ceftriaxone 2 g qd 12 1 1
Doxycycline 0.1 g bid + gentamicin 160,000 iu qd 7 1 1
Triple therapy Doxycycline 0.1 g bid + rifampicin 0.45–0.6 g qd + ceftriaxone 2 g qd 2–22 8 6 1 1
Monotherapy + Dual therapy + Triple therapy Doxycycline, streptomycin, levofloxacin, ceftriaxone, rifampicin, ciprofloxacin, gentamicin, minocycline, and multiple drug replacement regimens 12–27 7 4 2
Total 21 15 2 4